Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the...

by Abou-Alfa, G.K, Cheng, A.-L, El-Khoueiry, A.B, Kelley, R.K, Meyer, T., Milwee, S., Rimassa, L., Sen, S.
Published 2022

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the...

by Abou-Alfa, G.K, Cheng, A.-L, El-Khoueiry, A.B, Kelley, R.K, Meyer, T., Milwee, S., Rimassa, L., Sen, S.
Published 2022

First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers

by Abou-Alfa, G.K, Ansaldi, C., Awada, A., Bestion, E.N, Decaens, T., Dreyer, C., Halfon, P., Harding, J.J, Kotecki, N., Menut, A., Merle, P., Mezouar, S., Paradis, V., Rachid, M., Raymond, E., Roth, G.
Published 2022